
 
 The government’s recognition of MSD’s Keytruda (pembrolizumab) for reimbursement as the initial-line treatment for lung most cancers has accelerated the company’s advancement of yet another oncology pipeline constructed from the spine of Keytruda. 
 
 On Friday, the Ministry of Meals and Drug Security approved MSD to carry […]
Friday, May 27, 2022
Breaking News